{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:10:09Z","timestamp":1761765009291,"version":"3.44.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.urology.2007.08.028","type":"journal-article","created":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T08:26:27Z","timestamp":1201854387000},"page":"136-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Time to Prostate-Specific Antigen Nadir After Androgen Suppression Therapy for Postoperative or Postradiation PSA Failure and Risk of Prostate Cancer-Specific Mortality"],"prefix":"10.1016","volume":"71","author":[{"given":"Christine S.","family":"Chung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony V.","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2007.08.028_bib1","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.281.17.1591","article-title":"Natural history of progression after PSA elevation following radical prostatectomy","volume":"281","author":"Pound","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2007.08.028_bib2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/01.ju.0000100980.13364.a6","article-title":"10-year outcome for men with localized prostate cancer treated with external radiation therapy: results of a cohort study","volume":"171","author":"Zietman","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2007.08.028_bib3","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/jnci\/djg043","article-title":"Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy","volume":"95","author":"D\u2019Amico","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urology.2007.08.028_bib4","doi-asserted-by":"crossref","first-page":"6992","DOI":"10.1200\/JCO.2005.01.2906","article-title":"Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy","volume":"23","author":"Zhou","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2007.08.028_bib5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/jama.294.4.433","article-title":"Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy","volume":"294","author":"Freedland","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2007.08.028_bib6","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0022-5347(05)64559-4","article-title":"Prognostic significance of the nadir prostate specific antigen level after hormone therapy for prostate cancer","volume":"168","author":"Kwak","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2007.08.028_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.ju.0000129051.81608.d8","article-title":"The natural history of androgen independent prostate cancer","volume":"172","author":"Shulman","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2007.08.028_bib8","doi-asserted-by":"crossref","first-page":"6556","DOI":"10.1200\/JCO.2005.20.966","article-title":"Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failure","volume":"23","author":"Stewart","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2007.08.028_bib9","first-page":"1035","article-title":"Consensus statement\u2014guidelines for PSA following radiation therapy","volume":"37","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2007.08.028_bib10","series-title":"Survival Analysis: Techniques for Censored and Truncated Data","first-page":"243","article-title":"Semiparametric proportional hazards regression with fixed covariates","author":"Klein","year":"2003"},{"key":"10.1016\/j.urology.2007.08.028_bib11","first-page":"150","article-title":"Simultaneous inferences and other topics in regression analyses-1, in Applied Linear Regression Models","author":"Neter","year":"1983"},{"key":"10.1016\/j.urology.2007.08.028_bib12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non-parametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.urology.2007.08.028_bib13","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1080\/01621459.1993.10476289","article-title":"On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data","volume":"88","author":"Gaynor","year":"1993","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.urology.2007.08.028_bib14","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"key":"10.1016\/j.urology.2007.08.028_bib15","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1056\/NEJMoa040720","article-title":"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer","volume":"351","author":"Tannock","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2007.08.028_bib16","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa041318","article-title":"Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer","volume":"351","author":"Petrylak","year":"2004","journal-title":"N Engl J Med"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429507020109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429507020109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:47:09Z","timestamp":1758764829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429507020109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0090429507020109"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2007.08.028","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time to Prostate-Specific Antigen Nadir After Androgen Suppression Therapy for Postoperative or Postradiation PSA Failure and Risk of Prostate Cancer-Specific Mortality","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2007.08.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}